ALBioN - Artificial Ligament with Bioactive Nanostructure (OM-DTI LigaMimeticc Proj)
Lead Participant:
TIGENIX LIMITED
Abstract
This project was aimed at the development of a medical device for the regenerative repair of torn ligaments, using a proprietary and innovative platform technology for the production of smart, nanocomposite materials based on collagen, glycosaminoglycans and a bioactive calcium phosphate. This project activities built on this biomaterials technology to develop a product that would be both compatible with existing surgical techniques and capable of improving their outcomes. A key focus was the developemnt of a fibre extrusion technology for making working prototype of an implant for the repair of knee and shoulder tendon repair applications. The prototypes were tested in in-vitro and large-animal models. The four partners in this consortium comprise a world-leading centre for biomaterials resarch; a renowned institution for preclinical and clinical orthopaedic research; a leading manufacturer of medical-grade collagen; and an SME focussed on the development of novel products for the regenerative repair of articular joint injuries.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
TIGENIX LIMITED | £736,722 | £ 118,612 |
  | ||
Participant |
||
ENXRAY LIMITED | ||
UNIVERSITY OF CAMBRIDGE | £633,015 | |
DEVRO PLC | £97,871 |
People |
ORCID iD |